These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21842240)

  • 1. Breath-ammonia testing of healthy subjects and patients with cirrhosis.
    Adrover R; Cocozzella D; Ridruejo E; García A; Rome J; Podestá JJ
    Dig Dis Sci; 2012 Jan; 57(1):189-95. PubMed ID: 21842240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath and blood ammonia in liver cirrhosis.
    Shimamoto C; Hirata I; Katsu K
    Hepatogastroenterology; 2000; 47(32):443-5. PubMed ID: 10791209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath ammonia testing for diagnosis of hepatic encephalopathy.
    DuBois S; Eng S; Bhattacharya R; Rulyak S; Hubbard T; Putnam D; Kearney DJ
    Dig Dis Sci; 2005 Oct; 50(10):1780-4. PubMed ID: 16187173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.
    Spacek LA; Mudalel M; Tittel F; Risby TH; Solga SF
    J Breath Res; 2015 Dec; 9(4):047109. PubMed ID: 26658550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.
    Ditisheim S; Giostra E; Burkhard PR; Goossens N; Mentha G; Hadengue A; Spahr L
    BMC Gastroenterol; 2011 Dec; 11():134. PubMed ID: 22151412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.
    Keiding S; Pavese N
    Arch Biochem Biophys; 2013 Aug; 536(2):131-42. PubMed ID: 23726863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
    Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ammonia and endogenous benzodiazepine-like compounds in the pathogenesis of hepatic encephalopathy.
    Venturini I; Corsi L; Avallone R; Farina F; Bedogni G; Baraldi C; Baraldi M; Zeneroli ML
    Scand J Gastroenterol; 2001 Apr; 36(4):423-5. PubMed ID: 11336169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.
    Chen SJ; Wang LJ; Zhu Q; Cai JT; Chen T; Si JM
    World J Gastroenterol; 2008 Mar; 14(12):1914-8. PubMed ID: 18350632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Haj M; Rockey DC
    Am J Gastroenterol; 2020 May; 115(5):723-728. PubMed ID: 31658104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial pressure of NH₃ in cirrhotic patients with and without hepatic encephalopathy.
    He Y; Li G; Song H; Luo T; Gao B; Xu J
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):169-74. PubMed ID: 21725514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy.
    Iversen P; Sørensen M; Bak LK; Waagepetersen HS; Vafaee MS; Borghammer P; Mouridsen K; Jensen SB; Vilstrup H; Schousboe A; Ott P; Gjedde A; Keiding S
    Gastroenterology; 2009 Mar; 136(3):863-71. PubMed ID: 19041869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.
    Weissenborn K; Ahl B; Fischer-Wasels D; van den Hoff J; Hecker H; Burchert W; Köstler H
    Gut; 2007 Dec; 56(12):1736-42. PubMed ID: 17660226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?
    Papadopoulos N; Soultati A; Goritsas C; Lazaropoulou C; Achimastos A; Adamopoulos A; Dourakis SP
    J Clin Gastroenterol; 2010; 44(10):713-9. PubMed ID: 20495469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.
    Sugimoto R; Iwasa M; Maeda M; Urawa N; Tanaka H; Fujita N; Kobayashi Y; Takeda K; Kaito M; Takei Y
    Am J Gastroenterol; 2008 Jun; 103(6):1413-20. PubMed ID: 18510613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.